- 专利标题： Base-Modified Cytidine Nucleotides for Leukemia Therapy
-
申请号： US18670555申请日： 2024-05-21
-
公开(公告)号： US20240309031A1公开(公告)日： 2024-09-19
- 发明人: Pedro PINHO , Björn KLASSON , John OHD , Mark ALBERTELLA
- 申请人： MEDIVIR AB
- 申请人地址： SE Huddinge
- 专利权人： MEDIVIR AB
- 当前专利权人： MEDIVIR AB
- 当前专利权人地址： SE Huddinge
- 优先权： SE 507657 2018.06.21 JP 19090760 2019.05.13
- 主分类号： C07F9/6558
- IPC分类号： C07F9/6558 ; A61P35/02
摘要：
Compounds of the formula I
wherein X is a bond or —CH2, and pharmaceutically acceptable salts thereof are useful in the parenteral treatment of leukemia, myelodysplastic syndrome or lymphoma, especially in patients presenting with cytarabine resistance and/or over 60 years of age.
wherein X is a bond or —CH2, and pharmaceutically acceptable salts thereof are useful in the parenteral treatment of leukemia, myelodysplastic syndrome or lymphoma, especially in patients presenting with cytarabine resistance and/or over 60 years of age.
信息查询
